合作项目14
来源：市科协办公室
时间：2009-12-18点击：632
|
合作项目表 | |||||||
|
|
|
|
|
|
|
|
|
|
日期 | |||||||
| 项目名称 | 中文：作为中国旅美科协犹他分会的主席，希望能够了解国内各地对海外留学人员回国创业的政策，尤其是在信息、能源、环境、生物、医药等高科技产业领域的需求，以开通犹他州和国内合作交流的渠道。 | ||||||
| 英文：Development of Biomarq, a New Class of Bio-signal Biomarkers, with Bio-signal Analysis Monitoring (BAM) Technology | |||||||
| 项目承担单位 (个人)联络方式 | 单位 (个人) 名称 |
中文： | |||||
| 英文：NeuroTraq, Inc. | |||||||
| 地址 | 中文： | ||||||
| 英文：9750 South 300 West, Sandy UT 84070, USA | |||||||
| 联系人 | Xiaoming Sheng盛晓明 | ||||||
| 联系 方式 |
电话 | +1-801-213-3729 | 传真 | +1-801-581-3899 | xiaoming@ustc.edu | ||
| 合作需求概述 | □X 合资 □X 引进技术 □引进人才 □X 合作研发 □其他 请详细描述：寻求合作伙伴进行首期投资（50万元）以开展研发工作，一年后二期投资（500万元）完成市场开发。 | ||||||
| 项目 简介 |
NeuroTraq, Inc. (NTQ) is an early stage Corporation developing innovative biological information technologies. Advanced electrocardiogram (ECG) bio-signal processing is the focus of NeuroTraq’s recent technology development program. The ECG is used extensively to promptly diagnose critical cardiac conditions in Emergency Room Chest Pain Centers (CPCs) where over 5.5 million patients are treated for cardiac symptoms. Unfortunately, conventional EKG interpretation results in the CPCs are non-diagnostic in 50% of suspected cardiac cases. The inconclusive diagnoses result in hundreds of thousands of patients who do not get proper treatment and several hundred thousand unnecessary hospitalizations for people without serious conditions – leading to serious implications for patient survival, increased hospital costs, and ballooning malpractice lawsuits. Twenty percent of all malpractice claims against emergency physicians are related to improper cardiac condition diagnosis and treatment. NeuroTraq will use modern ECG technology to significantly, and cost effectively, improve electrocardiogram diagnosis of cardiac symptoms in CPC patients by providing more detailed, better structured, and relevant ECG supplementary data, through a technology platform called CardioTraq, to facilitate more accurate diagnoses by clinicians. The CardioTraq platform is based on technology licensed from the University of Utah and used with NTQ innovations to provide a new category of advanced electrocardiographic services. The CardioTraq platform is also applicable to other markets and will be developed in a three stage commercialization approach that adapts CardioTraq to specific requirements for new targeted markets and selected end users. | ||||||
| 项目单 位 (个人)介绍 |
|||||||
| 可行性分析 | |||||||
